Objetivo
Preventing immunological rejection of transplanted organs without the need for long-term use of pharmacological immunosuppression is a primary objective in transplantation medicine. Reducing the need for immunosuppression would dramatically improve the outcome for transplant recipients and reduce health costs for society. The means to achieve this goal has not been realised with pharmacological or biological agents yet. Conditioning the immune response of solid organ transplant recipients towards allograft acceptance using cell-based therapies is now becoming technically feasible and clinically promising. The central focus of our proposed cooperative work programme is to produce distinct populations of haematopoietic regulatory cells and comparatively test their safety and efficacy in minimising pharmacological immunosuppression in solid organ transplantation. Preparations of regulatory T cells, macrophages and dendritic cells will be licensed for clinical manufacture in outstanding research facilities across Europe, and subsequently, these different tolerance-promoting cell types will be assessed in a single Phase I/II clinical study for safety, clinical practicality and efficacy. The therapeutic potential of these cells will be directly compared using one, single clinical protocol. In addition, we will study the tolerogenic characteristics of these regulatory cell types at in-depth molecular and functional levels. These integrative, but very focused, research plans are expected to result in the identification of the most promising regulatory cell products for further testing, and commercial exploitation: the final outcome is to identify a cell product which has genuine potential to induce operational tolerance if correctly applied in a Phase IIb clinical trial. This objective can only be accomplished by the cooperation of the most experienced researchers in this field across Europe, in alliance with SMEs devoted to cell therapy.
Ámbito científico
Tema(s)
Convocatoria de propuestas
FP7-HEALTH-2010-single-stage
Consulte otros proyectos de esta convocatoria
Régimen de financiación
CP-IP - Large-scale integrating projectCoordinador
93053 Regensburg
Alemania
Ver en el mapa
Participantes (15)
WC2R 2LS London
Ver en el mapa
OX1 2JD Oxford
Ver en el mapa
10117 Berlin
Ver en el mapa
20132 MILANO
Ver en el mapa
44093 Nantes
Ver en el mapa
51429 Bergish Gladbach
Ver en el mapa
PE29 6XS Huntingdon
Ver en el mapa
79108 FREIBURG
Ver en el mapa
La participación finalizó
79100 FREIBURG IM BREISGAU
Ver en el mapa
53100 Siena
Ver en el mapa
53706 Madison Wi
Ver en el mapa
LE11 3TU Loughborough
Ver en el mapa
94607 OAKLAND CA
Ver en el mapa
02114 Boston Ma
Ver en el mapa
20132 Milano
Ver en el mapa